Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of the American Chemical Society|October 2, 2008
Strategy for employing unstabilized nucleophiles in palladium-catalyzed asymmetric allylic alkylationsBarry M Trost, David A ThaisrivongsJournal of the American Chemical Society|August 4, 2009
Palladium-catalyzed regio-, diastereo-, and enantioselective benzylic allylation of 2-substituted pyridinesBarry M Trost, David A ThaisrivongsAngewandte Chemie (International Ed. in English)|April 11, 2012
Palladium-catalyzed alkylation of 1,4-dienes by C-H activationBarry M Trost, Max M Hansmann, David A ThaisrivongsJournal of the American Chemical Society|July 21, 2011
Palladium-catalyzed asymmetric allylic alkylations of polynitrogen-containing aromatic heterocyclesBarry M Trost, David A Thaisrivongs, Jan HartwigJournal of the American Chemical Society|January 29, 2015
A new class of non-C2-symmetric ligands for oxidative and redox-neutral palladium-catalyzed asymmetric allylic alkylations of 1,3-diketonesBarry M Trost, Etienne J Donckele, David A Thaisrivongs, et al.Organic Letters|December 10, 2016
Synthesis of Verubecestat, a BACE1 Inhibitor for the Treatment of Alzheimer's DiseaseDavid A Thaisrivongs, Steven P Miller, Carmela Molinaro, et al.Organic Letters|February 27, 2018
A Next Generation Synthesis of BACE1 Inhibitor Verubecestat (MK-8931)David A Thaisrivongs, William J Morris, Lushi Tan, et al.Journal of the American Chemical Society|October 21, 2022
Total Synthesis of Aflastatin ADavid A Evans, Jason J Beiger, Jason D Burch, et al.The Journal of Organic Chemistry|November 27, 2018
Highly Diastereoselective Synthesis of a HCV NS5B Nucleoside Polymerase InhibitorYong-Li Zhong, Ed Cleator, Zhijian Liu, et al.Circulation|May 1, 2023
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G Johns, Louis-Charles Campeau, Puja Banka, et al.Pageof 2